top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

HEALTH

Digital Cognitive Therapy Delivers Striking Cognitive Gains for UK Care Home Residents

A digital therapeutic designed to combat cognitive decline in people with dementia has produced remarkable improvements in cognitive and emotional outcomes in a recent UK pilot.

 Featured Articles. 

7-format11240.jpg
HEALTH

WHO Prequalifies Shanchol®, Securing Global Supply of India’s Oral Cholera Vaccine

7-format11240.jpg
BIOTECH

Enhanced Genomics Secures $19M Series A Extension to Advance Therapeutics Pipeline

7-format11240.jpg
BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

7-format11240.jpg
BIOTECH

Cyclana Bio Secures £5M to Transform Drug Discovery for Endometriosis

7-format11240.jpg
BIOTECH

International Team to Build First Fully Synthetic Chloroplast Genomes

7-format11240.jpg
BIOTECH

SolasCure Receives FDA Fast Track Designation for Aurase Wound Gel in Treatment of Calciphylaxis Ulcers

7-format11240.jpg
HEALTH

Owlstone Medical Wins $49.1M ARPA-H Award for At-Home Multi-Cancer Detection

7-format11240.jpg
BIOPROCESSING

How Cell Culture Media Feeds the Future of Medicine

7-format11240.jpg
PHARMA

Vedanta Biosciences Announces Phase 2 Results for VE202 in Ulcerative Colitis, Strengthens Focus on Lead Program VE303

 Latest News. 

1st November, 2025

01.

Body Clock Protein Found to Protect the Brain by Boosting Vital Energy Molecule

Circadian regulator REV-ERBα emerges as a brain-specific controller of NAD+ and tau pathology.

28th October, 2025

02.

Qureight Model Shows Promise for Pulmonary Vascular Disease Management

Peer-reviewed study confirms the Vascul8™ model’s ability to improve patient care and reduce the need for invasive procedures following surgery for chronic thromboembolic pulmonary hypertension.

21st October, 2025

03.

Astellas Reports Long-Term Benefits and Strong Safety Profile for IZERVAY™ in Geographic Atrophy

GATHER2 extension data show sustained efficacy and no new safety concerns after 3.5 years of treatment.

20th October, 2025

04.

Cyclana Bio Secures £5M to Transform Drug Discovery for Endometriosis

Cambridge-based biotech pioneers tissue-level approach to women's health, aiming to close the gender gap in medical innovation.

Editor's Selects.

Weighing the Cost of Semaglutide

Women's Health Therapeutics Market Enters Transformative Growth Phase

Feeding The Future of Medicine

Biotechnology in Agriculture - Feeding the World’s Growing Population

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page